Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. Government revenue collected in recreational marijuana excise taxes totaled $31 million in fiscal year 2020.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? At this time, there is little in the way for combat-related PTSD treatment specifically. Let’s find out. .

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. The Guardian writes. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

AUGUST 12, 2021

loss per share, during the same period in 2020 (after including non-cash share-based compensation expense of $11.4 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. These include safer routes of administration, greater certainty of access, and better communication between patients and doctors.

Medicine 52

Medicine Legalization Chronic Pain Access 52

CannaMD

MARCH 4, 2020

The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. The goal of the CannaMD /Releaf partnership is to collect and leverage data-backed insights to improve the quality of healthcare for registered medical cannabis patients in Florida.

Patients 79

Patients Data Collective Treatment 79

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Veriheal

AUGUST 31, 2022

Dr. Alex Harocopos, who wrote a research letter on the prevention centers, explains that New York had 2,062 overdose fatalities in 2020, which the doctor describes as the deadliest year on record. Nonetheless, the data speaks differently. . Of the drugs linked to overdosing, fentanyl —an illegal opioid—was the most common.

Consumption 104

Consumption Data Treatment Collective 104

Cannabis Law Report

JANUARY 3, 2022

The Czech Republic legalized therapeutic cannabis for selected patients in 2015, and health insurance companies have been covering up to 90% of the cost of the treatment since 2020. A higher dose of THC (three times the current threshold) will also be allowed in technical cannabis and its derived products.

Media 52

Media Chronic Pain Patients Treatment 52

Cannabis Law Report

FEBRUARY 25, 2022

In 2020, New Mexico Court of Appeals Judge M. It is reasonably self-evident that the deduction from gross receipts for prescription drugs was similarly intended to make medical treatment more accessible, by lessening the expense to those who require it. NM Supreme Court tosses cannabis tax case.

Programs 52

Programs Collective Data Patients 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. 1, 2020, and July 31, 2021—a 43% increase from the same period a year before. Interestingly, although opioids work well for acute pain (e.g.,

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

AUGUST 2, 2021

In 2020, founders Daniel Goldberg , Tim Schlidt and Tony Eisenberg partnered to form Palo Santo, and formally launched the venture capital fund in 2021. Supported by a rapidly growing body of evidence and strong FDA support, psychedelic-assisted treatments represent a paradigm shift in mental healthcare. Tweet this.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

MARCH 17, 2022

tonnes of methylamphetamine, cocaine, MDMA and heroin was consumed in 2020-21, the fifth year of the Program. The national consumption of methylamphetamine, cocaine, MDMA and heroin increased year on year in the first four years of the Program (2016-17 to 2019-20), followed by a marked reduction in total consumption in year five (2020-21).

Consumption 52

Consumption Programs Data Treatment 52

Cannabis Law Report

NOVEMBER 9, 2021

(“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. It’s estimated that 2020 spending was about $48 million. . I never thought that would have been possible,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The search included studies through 11-May-2020. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

MARCH 9, 2022

” Since 2020, Numinus Bioscience has significantly amended its license to widen its range of research activities, with prior approvals allowing study of the following: DMT, Ketamine, LSD, MDMA, Mescaline, Psilocin, Psilocybin. . ” About Numinus.

Research and Development 52

Research and Development Therapy Access Medicine 52

Cannabis Law Report

JANUARY 17, 2022

This application claims the priority date of a preceding provisional application filed with the United States Patent and Trade Office on December 31, 2020. Telescope is a chemical technology company developing scalable, widely deployable synthetic processes to manufacture pharmaceuticals for the treatment of mental health.

Research and Development 52

Research and Development Pharmaceutical Access Medicine 52

Cannabis Law Report

SEPTEMBER 20, 2021

KWC is a limited liability corporation formed under the laws of Arizona , which operates 10 ketamine infusion treatment clinics, across Arizona , Colorado , Florida , Illinois , Minnesota , Nevada , Texas , and Washington. Transaction Highlights.

Treatment 52

Treatment Media Research and Development Patients 52

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. In March, 2016, State Bill 307 expanded access to full-strength medical marijuana to terminally ill patients who were determined by two doctors to have less than a year to live.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Key Priorities for 2020.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

CannaMD

JUNE 15, 2020

By early 2020 , nearly 3,000 hospitalizations and deaths were attributed to EVALI, and the American Medical Association had called for a ban on e-cigarette and vaping products. One possible inference from our results is that the presence of legal markets for marijuana has helped mitigate or may be protective against EVALI. Get Started.

Vaping 60

Vaping Legalization Marijuana Concentrates 60

Cannabis Law Report

DECEMBER 17, 2021

In 2020, the total prevalent cases of 22q11.2 deletion syndrome cases in the 7MM, accounting for approximately 42% of the total 7MM cases in 2020. deletion syndrome were in Germany and the least in Spain in 2020. deletion syndrome were in Germany and the least in Spain in 2020. deletion syndrome were 35,203 in 2020.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Canna Care Docs

DECEMBER 16, 2020

Between the pandemic and the political climate, 2020 hasn’t exactly been a walk in the park. It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

The Cannigma

AUGUST 24, 2021

In an interview in 2020, Emjay CEO Chris Vaughn said there are three keys to success in running a cannabis delivery company: great selection competitive prices getting the product to customers quickly. Launched in 2020, Tetragram is a free “smart, digital journal that helps you get the most out of medical cannabis.”.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Cannabis Law Report

DECEMBER 21, 2021

billion in 2020 (Grandview Research). The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

NOVEMBER 29, 2021

We’re walking the walk and we’re taking that public health approach to this crisis.”. — New Jersey Office of the Attorney General, 2020. billion (2020 dollars) over the past decade to enforce the drug war, amounting to an average of $1.2 In 2020, the nation took historic steps forward in dismantling the War on Drugs. [10]

Policy 52

Policy Decriminalization Treatment History 52

Veriheal

OCTOBER 20, 2021

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Cannabis Law Report

MARCH 30, 2020

Recent developments suggest the industry has not only escaped closure, but many states have relaxed existing restrictions to encourage greater patient access while containing the spread of the virus. The United States medical marijuana market is estimated to reach nearly $8 billion in sales in 2020 with annual growth around 17%.

Marijuana 59

Marijuana Dispensary Patients Business 59

Cannabis Law Report

JANUARY 9, 2022

Eighteen states have laws that legalize, tax, and regulate cannabis for adults 21 and older (the 2020 voter-approved adult-use legalization law in South Dakota was overturned by the state’s Supreme Court in November 2021). This document reviews each state’s adult-use cannabis tax structure, population, and revenue from legalization.

Collective 52

Collective Policy Retail Programs 52

CannaMD

APRIL 15, 2020

To learn more about medical marijuana treatment center (MMTC) delivery services, please see: Florida Dispensaries: COVID-19 Policies. Because many of these patients are among our more vulnerable populations, it is essential that they maintain uninterrupted, regulated access to lab-tested products during this time.

Policy 55

Policy Patients Dispensary Banking 55